Arrowstreet Capital
MDCO

Arrowstreet Capital’s Medicines Co MDCO Stock Holding History

Arrowstreet Capital’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-193,700
Closed -$5.54M – 1563
2015
Q2 		$5.54M Buy
193,700
+182,900
+1,694% +$5.09M 0.03% 400
2015
Q1 		$303K Buy
+10,800
New +$303K ﹤0.01% 902
2014
Q4 		– Sell
-116,585
Closed -$2.6M – 1379
2014
Q3 		$2.6M Sell
116,585
-142,302
-55% -$3.61M 0.01% 537
2014
Q2 		$7.52M Sell
258,887
-223,469
-46% -$5.97M 0.04% 348
2014
Q1 		$13.7M Buy
482,356
+407,681
+546% +$13.5M 0.08% 235
2013
Q4 		$2.88M Sell
74,675
-147,892
-66% -$5.29M 0.02% 570
2013
Q3 		$7.46M Buy
222,567
+63,884
+40% +$2.03M 0.05% 304
2013
Q2 		$4.88M Buy
+158,683
New +$5.31M 0.04% 332

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital's MDCO Position: Q3 2015 in Review

Arrowstreet Capital sold out of Medicines Co (MDCO) in Q3 2015, closing a stake of 193,700 shares — an estimated $5.54M sold.

Arrowstreet Capital first reported a position in MDCO in Q2 2013 and held it in 8 quarters. The position peaked at $13.7M in Q1 2014. 183 funds tracked by Wall St. Rank hold MDCO as of Q3 2015.

  • Arrowstreet Capital reported no remaining Medicines Co position as of Q3 2015 after selling out during the quarter.
  • Arrowstreet Capital sold 193,700 Medicines Co shares in Q3 2015, an estimated $5.54M.
  • Arrowstreet Capital first reported a position in Medicines Co in Q2 2013 and held it in 8 quarters.
  • Arrowstreet Capital's Medicines Co position peaked at $13.7M in Q1 2014.
  • 183 funds tracked by Wall St. Rank held Medicines Co as of Q3 2015.

Based on Arrowstreet Capital's 13F filing for Q3 2015, filed 5 Nov 2015.